A Conjugate Composed of Nerve Growth Factor Coupled to a Non-toxic Derivative of Clostridium botulinum Neurotoxin Type A can Inhibit Neurotransmitter Release in Vitro

Abstract Nerve growth factor (NGF) receptor binding, internalisation and transportation of NGF has been identified as a potential route of delivery for other molecules. A derivative of Clostridium botulinum neurotoxin type A (LHN) that retains catalytic activity but has significantly reduced cell-binding capability has been prepared and chemically coupled to NGF. Intact clostridial neurotoxins potently inhibit neurotransmitter release at the neuromuscular junction by proteolysis of specific components of the vesicle docking/fusion complex. Here we report that the NGF-LHN/A conjugate, when applied to PC12 cells, significantly inhibited neurotransmitter release and cleaved the type A toxin substrate. This work represents the successful use of NGF as a targeting moiety for the delivery of a neurotoxin fragment.

[1]  A. Granholm,et al.  A Non-invasive System for Delivering Neural Growth Factors across the Blood-Brain Barrier: A Review , 1998, Reviews in the neurosciences.

[2]  C. Shone,et al.  Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities , 1996, Journal of clinical microbiology.

[3]  R. Boyd,et al.  The Effect of Botulinum Neurotoxins on the Release of Insulin from the Insulinoma Cell Lines HIT-15 and RINm5F (*) , 1995, The Journal of Biological Chemistry.

[4]  M. Ehlers,et al.  NGF-stimulated retrograde transport of trkA in the mammalian nervous system , 1995, The Journal of cell biology.

[5]  M. Barbacid.  The Trk family of neurotrophin receptors. , 1994, Journal of neurobiology.

[6]  C. Geula,et al.  Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[7]  Thomas C. Südhof,et al.  Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25 , 1993, Nature.

[8]  M. Chao,et al.  Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Paul Tempst,et al.  SNAP receptors implicated in vesicle targeting and fusion , 1993, Nature.

[10]  C. Shone,et al.  Inhibition of calcium-dependent release of noradrenaline from PC12 cells by botulinum type-A neurotoxin. Long-term effects of the neurotoxin on intact cells. , 1992, European journal of biochemistry.

[11]  今泉 和則.  Specific cholinergic destruction in the basal magnocellular nucleus and impaired passive avoidance behavior of rodents , 1992 .

[12]  M. Tohyama,et al.  Specific cholinergic destruction in the basal magnocellular necleus and impaired passive avoidance behavior of rodents , 1991, Brain Research.

[13]  G. Schiavo,et al.  An intact interchain disulfide bond is required for the neurotoxicity of tetanus toxin , 1990, Infection and immunity.

[14]  F E Bloom,et al.  The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations , 1989, The Journal of cell biology.

[15]  G. Ahnert-Hilger,et al.  The tetanus toxin light chain inhibits exocytosis , 1989, FEBS letters.

[16]  C. Shone,et al.  A 50-kDa fragment from the NH2-terminus of the heavy subunit of Clostridium botulinum type A neurotoxin forms channels in lipid vesicles. , 1987, European journal of biochemistry.

[17]  H. Clark,et al.  Demonstration of the retrograde transport of nerve growth factor receptor in the peripheral and central nervous system , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  C. Shone,et al.  Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity. , 1985, European journal of biochemistry.

[19]  B. Ehrlich,et al.  Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[20]  L. Simpson.  The origin, structure, and pharmacological activity of botulinum toxin. , 1981, Pharmacological reviews.

[21]  K. Sandvig,et al.  Diphtheria toxin entry into cells is facilitated by low pH , 1980, The Journal of cell biology.

[22]  L. Greene,et al.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Stöckel,et al.  Comparison between the retrograde axonal transport of nerve growth factor and tetanus toxin in motor, sensory and adrenergic neurons , 1975, Brain Research.

[24]  V. Bocchini.  The nerve growth factor. Amino acid composition and physicochemical properties. , 1970, European journal of biochemistry.